inVentiv Health To Announce Third Quarter Results And Conduct Conference Call On Tuesday, November 7, 2006

SOMERSET, N.J., Oct. 5 /PRNewswire-FirstCall/ -- inVentiv Health, Inc. today announced that it will release its Third Quarter results and conduct a conference call on Tuesday, November 7, 2006 at 9:00 a.m. Eastern Time.

The conference call will be webcast live on the Internet at http://www.inventivhealth.com. To listen, please go to the site at least 15 minutes in advance of the call to register, download and install any necessary audio software. An archived webcast will also be available shortly after the call.

Conference Call Information: Tuesday, November 7, 2006, 9:00 a.m. Eastern Time Call in number: 877-336-9182 (Domestic) or 706-634-1065 (International)

A replay of the call will be available immediately following the call through November 14, 2006 at 800-642-1687. The conference ID number for the replay is 8313095.

About inVentiv Health

inVentiv Health, Inc. is the leading provider of commercialization and complementary services to the global pharmaceutical, life sciences and biotechnology industries. inVentiv delivers its customized clinical, sales, marketing and communications solutions through its three core business segments: inVentiv Clinical, inVentiv Communications and inVentiv Commercial. inVentiv Health currently works with over 200 unique pharmaceutical, biotech and life sciences clients, including all top 20 global pharmaceutical companies. For more information, visit http://www.inventivhealth.com.

Forward-Looking Information

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve known and unknown risks that may cause inVentiv Health's performance to differ materially. Such risks include, without limitation: changes in trends in the pharmaceutical industry or in pharmaceutical outsourcing; our ability to compete successfully with other services in the market; our ability to maintain large client contracts or to enter into new contracts; and, our ability to operate successfully in new lines of business. Readers of this press release are referred to documents filed from time to time by inVentiv Health, Inc. with the Securities and Exchange Commission for further discussion of these and other factors.

CONTACT: Investors/Corporate: John Emery, CFO, +1-732-537-4804,investor@inventivhealth.com; or Media: Felicia Vonella, +1-212-308-7155,fvonella@inventivhealth.com, both of inVentiv Health, Inc.

Web site: http://www.inventivhealth.com/